MarkAnthonyLombardoMD

PubMed

• D-Glucose-Derived 1,2,4-Trioxepanes: Synthesis, Conformational Study, and Antimalarial Activity.
  Sonawane DP, Corbett Y, Dhavale DD, Taramelli D, Trombini C, Quintavalla A, Lombardo M> ;Org. Lett.. 2015-08-21
• Effects of whole body vibration plus diet on insulin-resistance in middle-aged obese subjects.
  Bellia A, Sallì M, Lombardo M, D'Adamo M, Guglielmi V, Tirabasso C, Giordani L, Federici M, Lauro D, Foti C, Sbraccia P> ;Int J Sports Med. 2014-06-01
• BACOP/FR combination chemotherapy as front-line treatment of follicular lymphoma. A phase II study of the Gruppo Italiano Studio Linfomi (GISL).
  Luminari S, Lombardo M, Mammi C, Bellei M, Merli F, Stelitano C, Lazzaro A, Marasca R, Brugiatelli M, Federico M> ;J. Clin. Oncol.. 2006-06-20
• Interleukin-2 (IL-2) and 13-cis retinoic acid (RA) decrease vascular endothelial growth factor (VEGF) and prolong disease-free and overall survival in patients with no...
  Recchia F, Saggio G, Cesta A, Candeloro G, Nuzzo A, Lombardo M, Rea S> ;J. Clin. Oncol.. 2005-06-01
• 21 citations
  Treatment of bruxism in Huntington's disease with botulinum toxin.
  Maureen C. Nash, Richard B. Ferrell, Mark A. Lombardo, Robert B. Williams> ;The Journal of Neuropsychiatry and Clinical Neurosciences. 2004 Aug 1
• Role of UGT1A1, MTHFR AND TS gene polymorphisms in the prediction of irinotecan (CPT11) and raltitrexed (TOM) gastrointestinal toxicity in pre-treated patients (pts) w...
  Massacesi C, Terrazzino S, Marcucci F, Rocchi MBL, Cappelletti C, Giustini L, Lombardo M, Rinaldi L, Mattioli R, Bonsignori M> ;J. Clin. Oncol.. 2004-07-15
• Nutritional, glycometabolic and genetic factors affecting menarcheal age in cystic fibrosis.
  Arrigo T, De Luca F, Lucanto C, Lombardo M, Rulli I, Salzano G, Lombardo F> ;Diabetes Nutr. Metab.. 2004-04-01
• The first zinc-promoted, environmentally friendly, and highly efficient acetoxyallylation of aldehydes in aqueous ammonium chloride.
  Lombardo M, Girotti R, Morganti S, Trombini C> ;Chem. Commun. (Camb.). 2001-11-21
• A new protocol for the acetoxyallylation of aldehydes mediated by indium in THF.
  Lombardo M, Girotti R, Morganti S, Trombini C> ;Org. Lett.. 2001-09-20
• Ifosfamide, cisplatin, and 13-Cis retinoic acid for patients with advanced or recurrent squamous cell carcinoma of the head and neck: a phase I-II study.
  Recchia F, Lalli A, Lombardo M, De Filippis S, Saggio G, Fabbri F, Rosselli M, Capomolla E, Rea S> ;Cancer. 2001-08-15
• Entropy-controlled selectivity in the vinylation of a cyclic chiral nitrone. An efficient route to enantiopure polyhydroxylated pyrrolidines.
  Lombardo M, Fabbroni S, Trombini C> ;J. Org. Chem.. 2001-02-23
• The hydroboration of propargyl bromide. Simple one-Pot three-component routes to (Z)-1-bromoalk-1-en-4-ols and to anti-homoallylic alcohols.
  Lombardo M, Morganti S, Trombini C> ;J. Org. Chem.. 2000-12-15
• [Report of the hospital discharge of the patient with myocardial infarct].
  Lombardo M> ;Recenti Prog Med. 2000-12-01
• Mechanisms responsible for endothelial dysfunction associated with acute estrogen deprivation in normotensive women.
  Virdis A, Ghiadoni L, Pinto S, Lombardo M, Petraglia F, Gennazzani A, Buralli S, Taddei S, Salvetti A> ;Circulation. 2000-05-16
• METH-1, a human ortholog of ADAMTS-1, and METH-2 are members of a new family of proteins with angio-inhibitory activity.
  Vázquez F, Hastings G, Ortega MA, Lane TF, Oikemus S, Lombardo M, Iruela-Arispe ML> ;J. Biol. Chem.. 1999-08-13
• [Primary ureteral amyloidosis].
  Fernández H, Rovegno AR, Marrugar R, Lauterstein GA, Dávalos Mitchel M, Lombardo M, Avagnina A, Kahan A, Castaño E> ;Arch. Esp. Urol.. 1998-06-01
• Long-term effects of angiotensin-converting enzyme inhibitors and calcium antagonists on the right and left ventricles in essential hypertension.
  Lombardo M, Alli C, Broccolino M, Ferrari S, Montemurro L, Zaini G, Zanni D> ;Am. Heart J.. 1997-09-01
• Endogenous estrogen and acetylcholine-induced vasodilation in normotensive women.
  Pinto S, Virdis A, Ghiadoni L, Bernini G, Lombardo M, Petraglia F, Genazzani AR, Taddei S, Salvetti A> ;Hypertension. 1997-01-01
• The impact of rufloxacin given as prophylaxis to patients with cancer on their oral and faecal microflora.
  D'Antonio D, Pizzigallo E, Lacone A, Violante B, Di Marzio A, Lombardo M, Fioritoni G, Staniscia T, Romano F> ;J. Antimicrob. Chemother.. 1996-11-01
• Randomized trial of 5-fluorouracil and high-dose folinic acid with or without alpha-2B interferon in advanced colorectal cancer.
  Recchia F, Nuzzo A, Lalli A, Lombardo M, Di Lullo L, Fabiani F, Fanini R, Venturoni L, Torchio P, Peretti G> ;Am. J. Clin. Oncol.. 1996-06-01
• Kaposi's sarcoma with primary bone lesions in an HIV-seronegative man.
  Lombardo M, Girolomoni G, Spina V, Zambruno G, Giannetti A> ;Br. J. Dermatol.. 1996-05-01
• Symptoms and Helicobacter pylori infection in children.
  Sferlazzas C, Tuccari G, Lombardo M, Conti Nibali S, Di Pasquale G, Magazzú G> ;J. Pediatr.. 1996-04-01
• Corticotropin-releasing factor-binding protein: origins and possible functions.
  Petraglia F, Florio P, Gallo R, Salvestroni C, Lombardo M, Genazzani AD, Di Carlo C, Stomati M, D'Ambrogio G, Artini PG> ;Horm. Res.. 1996-01-01
• Activin A, corticotropin-releasing factor and prostaglandin F2 alpha increase immunoreactive oxytocin release from cultured human placental cells.
  Florio P, Lombardo M, Gallo R, Di Carlo C, Sutton S, Genazzani AR, Petraglia F> ;Placenta. 1996-01-01
• [Vascular remodeling].
  Lombardo M, Giannattasio C> ;G Ital Cardiol. 1995-11-01
• Join now to see all